Iftar Timings Mar 29 - Ramazan 18

Lahore
LHR
06:20 PM
Karachi
KHI
06:47 PM
Islamabad
ISB
06:26 PM
Peshawar
PWR
06:31 PM
Quetta
QTA
06:49 PM

News

Pfizer launches mRNA flu vaccine trial

September 28, 2021 10:42 AM


US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful Covid-19 shot.

The idea is to improve on the current generation of flu vaccines that have an efficacy of 40-60 percent against a disease that can cause up to 650,000 deaths a year.

"The Covid-19 pandemic allowed us to deliver on the immense scientific opportunity of mRNA," Kathrin Jansen, head of vaccine research at Pfizer, said in a statement.

"Influenza remains an area where we see a need for vaccines which could result in improved efficacy in any given season, and we believe mRNA is the ideal technology to take on this challenge."

The early-stage study will recruit more than 600 Americans aged 65 to 85, according to a company statement and a government website listing the trial. 

Specifically, Pfizer wants to compare the safety and level of immune response of a single, double and quadruple strain mRNA vaccine at different dosage levels versus a conventional, licensed quadruple strain vaccine.

Conventional seasonal flu vaccines are generally cultured by growing the virus inside chicken eggs or mammalian cells. 

The viruses are inactivated and processed to be turned into vaccines.

The process is fraught with challenges, including producing vaccines that evoke a strong response and keeping up with virus strain changes.

Experts have to predict the best match for next season's vaccine six months out.

The promise of mRNA (messenger ribonucleic) acid technology is that they only require the genetic sequence of the virus, or a specific part of it, enabling faster and more flexible production.

The human body reads the genetic code and produces virus-like cells that train the immune system to be prepared for the real thing.

Pfizer began work on its mRNA influenza vaccine in 2018 with its German partner BioNTech, which would receive a royalty upon approval and commercialization.

In the future, Pfizer plans to explore mRNA medicine against other respiratory viruses, cancer and genetic diseases.

Moderna likewise is working on an mRNA flu vaccine and one against respiratory syncytial virus (RSV).



Most Read

  1. Man murders young sister by smothering her with pillow in Toba Tek Singh Man murders young sister by smothering her with pillow in Toba Tek Singh
  2. Aitchison College students, parents stage protest against principal’s resignation Aitchison College students, parents stage protest against principal’s resignation
  3. Five Chinese among six killed in Shangla suicide bombing Five Chinese among six killed in Shangla suicide bombing
  4. Sahiba meets her father for the first time Sahiba meets her father for the first time
  5. Maaz Safder regrets 4-year relationship with wife Saba Maaz Safder regrets 4-year relationship with wife Saba
  6. ‘Khaie's incredible ending receives rave reviews and big applause ‘Khaie's incredible ending receives rave reviews and big applause

Opinion

  1. IMEC to sabotage CPEC
    IMEC to sabotage CPEC

    By Dr Asif Channer

  2. 1947 TO FORM 47
    1947 TO FORM 47

    By Dr Asif Channer

  3. Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....
    Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....

    By Ali Ramay

  4. Global race: China will reduce its unnecessary expenses
    Global race: China will reduce its unnecessary expenses

    By Ali Ramay

  5. Channer Pir: The Great Saint of Cholistan
    Channer Pir: The Great Saint of Cholistan

    By Dr Asif Channer

  6. Literate the Religious Illiterate
    Literate the Religious Illiterate

    By Dr Asif Channer